retatrutide at night or morning Best time to take VisualAbstract: Retatrutide reduces body weight

The Zepbound KwikPen will be covered with Medicare Bridge

The trade-off: retatrutide produces substantially higher weight loss with a higher discontinuation rate

Triple Agonist vs Dual Agonist Comparison Contents Key Takeaways Two Compounds, One Manufacturer, Different Receptor Counts Weight Loss: The Numbers Side by Side Mechanism Breakdown: What the Third Receptor Adds Safety: Where the Tradeoffs Appear Evidence Quality: Phase 2 vs Phase 3 Where Each Compound Might Win The Bottom Line Explore Research Peptides Retatrutide 12mg 24.2% body weight lost (Phase 2, 48 wk) vs Tirzepatide 15mg 22.5% body weight lost (Phase 3, 72 wk) 3 vs 2 receptor targets (retatrutide vs tirzepatide) 63% vs 57% reached 20%+ weight loss (highest dose arms) Eli Lilly same manufacturer for both compounds Sources: Retatrutide Phase 2 (NEJM, 2023), SURMOUNT-1 (NEJM, 2022)

Switching Trulicity Wegovy Protocol Switching from Trulicity to Wegovy is common for patients who need greater weight loss effects beyond what Trulicity provides

Add more vegetables, lean proteins, and whole foods to your diet

Eli Lilly has also issued its own stark warning